MondayJan 09, 2023 2:12 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Kicks Off New Year with Multiple New Contracts, Announces Planned Path to Profitability

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced that it has secured four new contracts in a successful start of 2023. Under the contracts, Knightscope will deploy three K5 Autonomous Security Robots (“ASRs”) and five K1 Blue Light Towers. The deployment locations include an existing Knightscope channel partner’s regional corporate office in Jacksonville, Florida, an Illinois-based casino, as well as the parking lot of an apartment complex for a well-known learning institution. A teaching hospital has also purchased five K1 Blue Light Towers to improve communications and safety on its New…

Continue Reading

MondayJan 09, 2023 1:10 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombia, US Facilities to Distinguish Itself Within Highly Competitive Space

Flora Growth Corp. (NASDAQ: FLGC), a cannabis cultivator and global distributor, is a rapidly growing house of brands building customer bases and distribution channels across international lines as it aims to distinguish itself within a highly competitive arena. “Much of Flora Growth’s strength lies in its licensed cultivation, extraction and isolation facility located in northern Colombia’s fertile climate, where an experienced labor force is helping the nation emerge from decades of drug war illicit trade into a recognized and regulated market,” a recent article reads. “From its 247 acres of growing fields, the company’s harvests move into a production pipeline…

Continue Reading

MondayJan 09, 2023 12:18 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Poised to Potentially Change History

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is enrolling patients in the United States and Europe for its potentially pivotal global clinical trial in humans for its lead drug candidate designed to treat glioblastoma multiforme (“GBM”), a common and one of the most aggressive primary brain cancers. “The drug, Berubicin, is an anthracycline chemotherapy agent that apparently has the unique ability to cross the blood-brain barrier to target tumors directly. The inability of anthracyclines to cross the blood-brain barrier has been identified as a major obstacle in treating aggressive brain tumors such as GBM and creates an opportunity for CNS…

Continue Reading

MondayJan 09, 2023 10:35 am

QualityStocksNewsBreaks — MetAlert Inc. (MLRT) Featured in Ludlow Research Analyst Brief

MetAlert (OTC: MLRT), a pioneer in location-sensitive, health-monitoring devices and wearable technology products for remote patient monitoring, spotlighted in a recent Q&A analyst report released by Ludlow Research. In the article, MLRT representations respond to questions, providing an overview of the company and discussing specific topics investors and shareholders might be interested in. The report delved into the company’s recent restructuring, name change and ticker symbol change, with the company stating that “we waited patiently to do this until we had a clean balance sheet and were prepared to take the company to the next level.” The report noted that…

Continue Reading

MondayJan 09, 2023 10:25 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Status Update on Clinical Development Programs

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), is discussing upcoming priorities and near-term milestones regarding the status of its two clinical programs aimed at addressing multiple mental health conditions: CYB003 and CYB004. Designed for the treatment of Major Depressive Disorder (“MDD”), CYB003 is currently in a phase 1/2a clinical trial. CYB003 is a deuterated psilocybin analog. CYBN anticipates releasing an interim readout from the trial by the end of February 2023, which will provide an initial understanding of the safety and pharmacokinetic (“PK”) profile of the substance in humans. This interim data will…

Continue Reading

FridayJan 06, 2023 1:39 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Eyes Transition of ZVS Prototype from Lab to Real-World Demonstrations

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a company focused on developing transformative power conversion technologies, recently completed its 800-volt, 250-kilowatt Zero Voltage Switching (“ZVS”) traction inverter commercial prototype, advancing from a 10-kilowatt technical proof of concept in just one year. “Hillcrest’s ZVS or soft switching capabilities will seek to overcome challenges habitually found in hard-switched wide-bandgap devices such as silicon carbide (‘SiC’) traction inverters. Through the material elimination of switching losses, Hillcrest’s inverter technology has been shown to reduce the thermal management needed across the entire powertrain system. This, in turn, can result in substantial savings in the manufacturing process, reducing…

Continue Reading

FridayJan 06, 2023 1:30 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Changing How Commercial Real Estate Owners Optimize Energy Assets

Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is helping to advance progress on the greenhouse gas reduction front. “The company is making it easier and cost effective for those in the commercial real estate industry to acquire the necessary solutions for solar, cogeneration, energy storage, and electric vehicle infrastructure, as well as driving intelligent efficiency retrofits for community-scale applications… Correlate provides proprietary analytics and advisement for companies seeking to reduce the carbon footprint of their buildings before helping clients navigate the tricky journey toward managing and financing infrastructure…

Continue Reading

FridayJan 06, 2023 1:00 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Releases Projections for Double-Digit Revenue Growth in 2023

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process and providing its Fr8App platform for business-to-business, cross-border shipping in the USMCA region, has announced its 2023 guidance for revenue. According to the announcement, the company anticipates revenue this year to reach somewhere between $36 to $42 million; the company reported 2022 revenue of approximately $26 to $27 million.  “We look forward to continued growth in our cross-border and domestic FTL offerings over the course of the next 12 to 24 months and come into 2023 with a strong pipeline of existing customers…

Continue Reading

FridayJan 06, 2023 11:13 am

QualityStocksNewsBreaks – Cepton Inc.’s (NASDAQ: CPTN) Vista-X120 Plus Featured in FreightWaves Article

Cepton (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, was featured in a recent article published by FreightWaves. The piece, written by Jack Daleo and titled “Cepton unveils slimmed-down lidar solution,” discusses the Vista-X120 Plus, which offers easy integration at a height of 30 mm. “As the autonomous vehicle industry begins to gather steam, manufacturers of lidar — short for light detection and ranging — are trying to do more with less. Cepton (NASDAQ: CPTN), one of the few publicly traded lidar companies in the U.S., on Tuesday unveiled the Vista-X120 Plus, billed as ‘the world’s slimmest software…

Continue Reading

FridayJan 06, 2023 10:16 am

QualityStocksNewsBreaks – Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF), Snowflake Partner to Help Fill Gap in US Data Market

Reklaim (TSX.V: MYID) (OTCQB: MYIDF), a leader in privacy-compliant data, today announced its collaboration with Snowflake, the Data Cloud company, to offer two compliant data sets on Snowflake Marketplace. These include a data set of individual consumers who have explicitly opted-in to sharing their sensitive personal data (“SPI”) for marketing purposes, as well as a do-not-sell data set of consumers who have specifically opted out of having their data sold. “With the enforcement period of CCPA beginning in January of 2023, offering distinct consumer consent for SPI data and do-not-sell signals to companies looking to ensure their data remains compliant…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered